InsidersTradesSigma
Track the 润都股份 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 润都股份 has published 1 public disclosures. Market capitalisation: €3.4bn. The latest transaction was filed on 17 December 2021 (Purchase). Among the most active insiders: 石瑞婷. The full history is free.
1
Insider Decl.
n/a
Thresholds
€6,591
1 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,021 of 28,836 companies
28.1
score / 100
Value28
Quality28
FCF yld2.5%
Earn yld-1.9%
EV/EBITDA40.7x
ROE-4.5%
Gross mgn39%
Net mgn-5.4%
Debt/EBITDA5.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 December 2021
About 润都股份
润都股份 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of pharmaceutical products.